Global Health reported record quarterly revenue of ₹1,304 crore, driven by a surge in patient volumes. While operational performance was strong, net profit remained flat at ₹159 crore, impacted by a higher base from previous year gains. Investors are now monitoring how the company manages the large capital spending required for its 2,950-bed expansion pipeline.
Global Health, which operates the Medanta hospital chain, reported a strong start to the new financial year with its first-quarter results showing significant operational growth. The company achieved a record revenue of ₹1,304 crore, marking a 26.5% increase compared to the same period last year. Earnings before interest, taxes, depreciation, and amortization (EBITDA), a key measure of operational profitability, also grew by 26.3% to reach ₹286.7 crore.
Operational Efficiency and Patient Growth
The financial growth was supported by higher hospital activity. Inpatient volumes rose by 27.7%, while outpatient numbers saw a jump of 34.5%. A critical metric for hospital operators is bed occupancy, which reached 63% across the company’s network. Excluding the newer Noida facility, which is still in its early operational phase, occupancy stood at 66%. Higher occupancy helps hospitals better manage their fixed costs, such as medical equipment and facility maintenance. The company also made progress in its newer hospitals, as the Noida facility successfully narrowed its EBITDA loss to ₹49 million, down from ₹236 million in the same quarter last year.
Expansion Strategy and Capital Requirements
Global Health is currently in a phase of significant growth, having added 72 beds during the quarter, mainly in Noida and Lucknow. Management is pursuing an aggressive expansion plan, with 2,950 new beds planned across five greenfield projects. This includes a new 80-bed cancer facility in Indore and an increased capacity of 650 beds for the upcoming Guwahati project. While this expansion aims to capture growing demand for specialized healthcare services, these projects require heavy capital spending. Investors may monitor whether this aggressive growth plan impacts the company’s cash flow or debt levels in the coming quarters.
Sector Context and Market Performance
The healthcare sector in India continues to see high demand for quality tertiary care, which has supported the revenue growth of major hospital chains. However, the industry is capital-intensive, and profitability can be influenced by the time it takes for new facilities to achieve high occupancy levels. On the National Stock Exchange, Global Health shares closed at ₹1,423 on Thursday, reflecting a slight dip of 0.69% prior to the result announcement.
Looking ahead, the key monitorable for shareholders will be the execution of the planned hospital capacity. Specifically, the ability of new facilities like the Noida and Guwahati hospitals to reach break-even quickly will be essential to maintaining profit margins as the company balances its massive expansion pipeline with operational costs.